Ankyrins and Spectrins in Cardiovascular Biology and Disease

Mona M El Refaey1,2, Peter J Mohler1,2,3

  • 1Dorothy M. Davis Heart and Lung Research Institute, Wexner Medical Center, The Ohio State University, Columbus, OH, United States.

Frontiers in Physiology
|November 23, 2017
PubMed

Insights

Ankyrins and spectrins are vital proteins in heart function and disease. Their dysfunction is linked to cardiac arrhythmias, heart attacks, and atrial fibrillation.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Protein Interactions

Background:

  • Ankyrins are crucial adaptor proteins for cardiac membrane proteins, signaling molecules, and cytoskeletal elements.
  • Ankyrin dysfunction is implicated in various cardiovascular diseases, including cardiac arrhythmia.
  • Ankyrin-B syndrome and Brugada syndrome are examples of human diseases linked to ankyrin variants.

Purpose of the Study:

  • To review the roles of ankyrins and spectrins in cardiovascular physiology.
  • To highlight the connection between ankyrin- and spectrin-based pathway dysfunction and cardiovascular disease.
  • To emphasize the importance of ankyrin-spectrin interactions in cardiac ion channel and signaling complex regulation.

Main Methods:

  • Literature review of human and animal model findings.
  • Analysis of genetic variants associated with cardiovascular phenotypes.
  • Examination of ankyrin and spectrin roles in cardiac ion channel and signaling complex regulation.

Main Results:

  • Ankyrins are essential for normal cardiac physiology and are implicated in cardiovascular disease.
  • Ankyrin-B and ankyrin-G pathways are linked to cardiac arrhythmias, myocardial infarction, and atrial fibrillation.
  • Ankyrin-spectrin interactions are critical for cardiac function and the regulation of ion channels and signaling complexes.

Conclusions:

  • Ankyrins and spectrins play critical roles in cardiovascular health and disease.
  • Dysfunction in ankyrin- and spectrin-based pathways contributes to acquired cardiovascular conditions.
  • Understanding these protein interactions is key to addressing cardiovascular diseases.

Related Concept Videos

Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
4.2K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.3K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.2K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.0K
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.3K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.6K